JP2005145941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005145941A5 JP2005145941A5 JP2003397549A JP2003397549A JP2005145941A5 JP 2005145941 A5 JP2005145941 A5 JP 2005145941A5 JP 2003397549 A JP2003397549 A JP 2003397549A JP 2003397549 A JP2003397549 A JP 2003397549A JP 2005145941 A5 JP2005145941 A5 JP 2005145941A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- meca
- amount
- administered
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- HUJXGQILHAUCCV-MOROJQBDSA-N 3-iodobenzyl-5'-N-methylcarboxamidoadenosine Chemical compound O[C@@H]1[C@H](O)[C@@H](C(=O)NC)O[C@H]1N1C2=NC=NC(NCC=3C=C(I)C=CC=3)=C2N=C1 HUJXGQILHAUCCV-MOROJQBDSA-N 0.000 claims 5
- 230000036765 blood level Effects 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/705,262 US20050101560A1 (en) | 2003-11-12 | 2003-11-12 | Method of treating an individual with methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl] beta-D-ibofuronamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005145941A JP2005145941A (ja) | 2005-06-09 |
| JP2005145941A5 true JP2005145941A5 (enExample) | 2006-01-19 |
Family
ID=34552317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003397549A Pending JP2005145941A (ja) | 2003-11-12 | 2003-11-27 | メチル１−［Ｎ６−（３−ヨードベンジル）−アデニン−９−イル］−β−Ｄ−イボフロナミドを個体に処置する方法 |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US20050101560A1 (enExample) |
| JP (1) | JP2005145941A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2227234B1 (en) | 2007-10-15 | 2014-05-07 | Can-Fite Biopharma Ltd. | Method for inducing hepatocyte proliferation and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688774A (en) * | 1993-07-13 | 1997-11-18 | The United States Of America As Represented By The Department Of Health And Human Services | A3 adenosine receptor agonists |
| DE69428536T2 (de) * | 1993-07-13 | 2002-06-06 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | A3 -adenosin -rezeptor agonisten |
-
2003
- 2003-11-12 US US10/705,262 patent/US20050101560A1/en not_active Abandoned
- 2003-11-27 JP JP2003397549A patent/JP2005145941A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006504795A5 (enExample) | ||
| WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
| JP2005515966A5 (enExample) | ||
| NL300889I2 (nl) | Trifluridine in combinatie met tipiracilhydrochloride | |
| JPH11139971A5 (enExample) | ||
| NO330947B1 (no) | Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand | |
| ATE350040T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
| ES2089027T3 (es) | Forma de dosificacion transmucosica. | |
| JP2010503695A5 (enExample) | ||
| EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
| WO1999059544A3 (en) | Orally disintegrable tablets | |
| JP2009536147A5 (enExample) | ||
| WO2005039499A3 (en) | Rapidly disintegrating film | |
| CU23468B7 (es) | Forma de dosificación de pramipexol en una dosis única diaria | |
| AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
| JP2009543885A5 (enExample) | ||
| JP2010522137A5 (enExample) | ||
| JP2006512324A5 (enExample) | ||
| WO2002024203A3 (en) | Controlled release formulations for oral administration | |
| BRPI0609984A2 (pt) | uso de zolpidem ou um sal do mesmo | |
| Grace et al. | Tooth erosion caused by chewing aspirin | |
| EP1393734A4 (en) | DRUG AGAINST DARMER DISEASES | |
| JP2005525329A5 (enExample) | ||
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| RU2004129284A (ru) | Амброксол для лечения болей в полости рта и глотки |